Ortho-Clinical Diagnostics

Type: Company
Name: Ortho-Clinical Diagnostics
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

3 Points Showing Why Medtech is Having a Great 2014 So Far

Postedin Medical Device Business by Arundhati Parmar on August 20, 2014A new report reviewing the first six months of the year paints an optimistic picture of the medtech industry.2013 was a year when M&A activity, VC funding and regulatory approvals ... [Published Medical Device & Diagnostic Industry - Aug 20 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Ortho-Clinical Diagnostics, Inc. Collaborates with Astute Medical, Inc.

Ortho-Clinical Diagnostics, Inc. (OCD) announced that it has entered into a strategic partnership with Astute Medical, Inc., to develop and commercialise Astute’s NEPHROCHECK® Test and ASTUTE140® Meter in certain markets in Europe.The NEPHROCHECK® Test ... [Published Asian Hospital & Healthcare Management - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Carlyle closing in on Acosta deal - report

(M&A Navigator via COMTEX News Network) -- 29 July 2014 - US private equity investor The Carlyle Group LP (NASDAQ:CG) is poised to strike a deal with sector player Thomas H Lee Partners LP for the acquisition of Florida-based retail marketing company ... [Published PredictWallStreet - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 6 reports

Ortho-Clinical Diagnostics and Astute Medical to Develop Acute Kidney Injury Tests

Ortho-Clinical Diagnostics has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK ® Test and ASTUTE140 ® Meter in certain markets in Europe ... [Published PharmaceuticalProcessing - Jul 28 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Johnson & Johnson ( NYSE: JNJ     ) held a conference call last week to go over the results of its second-quarter financials and give investors a taste of what's to come. Here are three quotes from the call and some commentary about why they're so i ... [Published Motley Fool Discussion Boards - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Johnson and Johnson sees further growth in Q2 2014

:41 in Medical Company Financials Johnson and Johnson has announced its financial results for the second quarter of 2014, during which it generated a three-month sales total of $19.5 billion (11.42 billion pounds). This represents a year-on-year increase ... [Published Zenopa - Jul 21 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Johnson & Johnson Earnings: New Blockbuster Drug Olysio Lifts Sales But May Face Competition Soon

Johnson & Johnson recently released its second quarter results. This can be attributed to the competition that its new blockbuster drug Olysio is likely to face going forward, as well as the impact of divestiture of Ortho-Clinical Diagnostics. Not a lot ... [Published Atlanta Journal And Constitution - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

J&J earnings beat expectations

Johnson & Johnson reported quarterly earnings and revenue that beat analysts' expectations on Tuesday.The company posted second-quarter earnings of $1.66 per share, up from $1.48 a share in the year-earlier period.Revenue increased to $19.5 billion from ... [Published CNBC - Jul 15 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company

RARITAN, N.J.--(BUSINESS WIRE)--Today Ortho-Clinical Diagnostics, Inc. (OCD) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group (NASDAQ: CG) from Johnson & Johnson. ... [Published Business Wire Health News - Jul 08 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

J&J completes divestiture of Ortho-Clinical Diagnostics business to Carlyle Group

Johnson & Johnson has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.Under the terms of the transaction, The Carlyle Group has acquired the Ortho-Clinical ... [Published PharmaBiz - Jul 02 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Robert Yates to be named COO of Carlyle’s OCD

The Carlyle Group has selected Robert Yates as chief operating officer of Ortho-Clinical Diagnostics subject to the close of Carlyle’s acquisition of OCD from Johnson & Johnson . In this newly-created role, Yates will report directly to incoming ... [Published PE Hub Blog - Jun 16 2014]
First reported Feb 27 2014 - Updated Feb 27 2014 - 4 reports

Carlyle names new chairman and CEO for OCD

Carlyle said Thursday that it has named Dr. Martin D. Madaus to become chairman and CEO of Ortho-Clinical Diagnostics . The appointment will become effective following the closing of Carlyle’s acquisition of OCD from Johnson & Johnson , which is ... [Published PE Hub Blog - Feb 27 2014]

Quotes

Two other top deals of the year, aside from Proteus' gigantic haul are HeartFlow's $104.7 million Series C round and Adaptive Biotechnologies " $100 million Series D round, the report noted."
Professor Vincent added: "Proxima has the potential to bring about a paradigm shift in the intensive and critical care setting. I look forward to working closely with the MAB and contributing to Proxima's future success following its commercial launch in the near future."
"Astute's innovative approach and product is a perfect fit with the commercial strength of OCD and our desire to advance important new diagnostic tests" commented Dr. Martin D Madaus , OCD chairman and chief executive officer
...new product launches and the progress we have made in achieving our near-term priorities," said Alex Gorsky , Chairman and Chief Executive Officer. "Significant advancements are being made in the treatment options and access to care for patients and customers around the world. Our diversified business model, focus on long-term growth drivers and talented colleagues position us well in this evolving and dynamic global healthhealth care market."

More Content

All (55) | News (29) | Reports (0) | Blogs (22) | Audio/Video (0) | Fact Sheets (1) | Press Releases (3)
sort by: Date | Relevance
3 Points Showing Why Medtech is Having a Great ... [Published Medical Device & Diagnostic Industry - Aug 20 2014]
Sphere Medical : Prof JL Vincent joins Medical ... [Published 4 Traders - Aug 11 2014]
Hologic's (HOLX) CEO Stephen MacMillan on Q3 20... [Published Seeking Alpha - Jul 31 2014]
Carlyle: Europe, Japan Price Discount Too Great... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
Ortho-Clinical Diagnostics, Inc. Collaborates w... [Published Asian Hospital & Healthcare Management - Jul 30 2014]
Carlyle closing in on Acosta deal - report [Published PredictWallStreet - Jul 29 2014]
Ortho-Clinical Diagnostics and Astute Medical t... [Published PharmaceuticalProcessing - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published The CW44 Tampa Bay - Jul 28 2014]
Astute Medical And Ortho-Clinical Diagnostics E... [Published Vision Monday - Jul 28 2014]
Astute Medical And Ortho-Clinical Diagnostics E... [Published PR Newswire: Health - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Technology News - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Health News - Jul 28 2014]
Johnson & Johnson Reports 2014 Second-Quarter R... [Published HispanicBusiness.com - Jul 23 2014]
3 Quotes From Johnson & Johnson's Conference Ca... [Published Motley Fool Discussion Boards - Jul 22 2014]
Market Report, "ARK Diagnostics, Inc. - Product... [Published SBWire - Jul 21 2014]
Johnson and Johnson sees further growth in Q2 2014 [Published Zenopa - Jul 21 2014]
Innovator Liability at 100 [Published Drug and Device Law - Jul 18 2014]
Andrew RT Davies praises new play area at Ty Hafan [Published Penarth Times - Jul 18 2014]
Robert McCormack to Present at Biomarker Meetin... [Published PR inside - Jul 18 2014]
Johnson & Johnson Earnings: New Blockbuster Dru... [Published Atlanta Journal And Constitution - Jul 16 2014]
J&J profits climb on new-drug sales [Published Melbourne Age - Jul 15 2014]
Johnson & Johnson's (JNJ) CEO Alex Gorsky on Q2... [Published Seeking Alpha - Jul 15 2014]
J&J med tech sales remain relatively flat for s... [Published FierceMedicalDevices - Jul 15 2014]
J&J earnings beat expectations [Published CNBC - Jul 15 2014]
Medtronic, Thermo Fisher Making Largest Medtech... [Published QMED - Jul 15 2014]
Why Johnson & Johnson Will Move the Dow Tomorrow [Published Motley Fool - Jul 14 2014]
Ortho-Clinical Diagnostics, Inc. Announces Exec... [Published Business Wire Health News - Jul 08 2014]
J&J completes divestiture of Ortho-Clinical Dia... [Published PharmaBiz - Jul 02 2014]
Johnson & Johnson Completes Divestiture Of Orth... [Published Financial Services - Jun 30 2014]
The 5 Most-Loved Stocks This Quarter [Published Wall St. Cheat Sheet - Jun 20 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Carlyle: Europe, Japan Price Discount Too Great... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
Carlyle Co-Founders and Co-Chief Executives William Conway (left) and David Rubenstein.Bloomberg News/Simon Dawson Carlyle Group LP, which has been investing capital more quickly this year than many of its peers, believes bargains lie in Europe and ...
Astute Medical And Ortho-Clinical Diagnostics E... [Published PR Newswire: Health - Jul 28 2014]
SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Technology News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Health News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Innovator Liability at 100 [Published Drug and Device Law - Jul 18 2014]
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say?Certainly not years; the awful Conte v. Wyeth, Inc., 85 Cal. Rptr.3d 299, (Cal. App. 2008), decision just turned six – this blog is older ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Johnson & Johnson Completes Divestiture Of Orth... [Published Financial Services - Jun 30 2014]
Robert Yates to be Named Chief Operating Office... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
Johnson & Johnson Announces Acceptance Of Bindi... [Published Financial Services - Mar 31 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.